Exact Mass: 325.0773

Exact Mass Matches: 325.0773

Found 61 metabolites which its exact mass value is equals to given mass value 325.0773, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pancratistatin

(1,3)Dioxolo(4,5-j)phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R-(1alpha,2beta,3alpha,4alpha,4aalpha,11bbeta))-

C14H15NO8 (325.0798)


Pancratistatin is a citraconoyl group. Pancratistatin is a natural product found in Delphinium denudatum, Hymenocallis speciosa, and other organisms with data available. Pancratistatin is a isoquinoline alkaloid from amaryllis with antineoplastic activity.

   

Midazolam

12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene

C18H13ClFN3 (325.0782)


A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. [PubChem] Midazolam is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3023 CONFIDENCE standard compound; INTERNAL_ID 1559 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

zofenoprilat

Zofenoprilate; Zofenoprilatum

C15H19NO3S2 (325.0806)


A proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-2-methyl-3-sulfanylpropanoyl group. The active metabolite of zofenopril. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

Diniconazole

Pesticide6_Diniconazole_C15H17Cl2N3O_(1E)-1-(2,4-Dichlorphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol

C15H17Cl2N3O (325.0749)


C254 - Anti-Infective Agent > C514 - Antifungal Agent CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10020; ORIGINAL_PRECURSOR_SCAN_NO 10019 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10120; ORIGINAL_PRECURSOR_SCAN_NO 10118 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10087; ORIGINAL_PRECURSOR_SCAN_NO 10086 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10071; ORIGINAL_PRECURSOR_SCAN_NO 10069 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10044; ORIGINAL_PRECURSOR_SCAN_NO 10043 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10088; ORIGINAL_PRECURSOR_SCAN_NO 10086

   

Dihyroxy-1H-indole glucuronide I

(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-[(5-hydroxy-1H-indol-6-yl)oxy]oxane-2-carboxylic acid

C14H15NO8 (325.0798)


Dihyroxy-1H-indole glucuronide I is a conjugate of dihyroxy-1H-indole and glucuronide I. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)

   

Basimglurant

2-chloro-4-{2-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl]ethynyl}pyridine

C18H13ClFN3 (325.0782)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1]. Basimglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

Diniconazole

1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol

C15H17Cl2N3O (325.0749)


   

isoxazolyl penicillin

6-{[hydroxy(5-methyl-1,2-oxazol-4-yl)methylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C13H15N3O5S (325.0732)


   

Lipo-pab

4-[5-(1,2-dithiolan-3-yl)pentanamido]benzoic acid

C15H19NO3S2 (325.0806)


   
   

arcyriaflavin a

arcyriaflavin a

C20H11N3O2 (325.0851)


   

Arcyriacyanin A

Arcyriacyanin A

C20H11N3O2 (325.0851)


   
   

2,6-Bis(2-pyridylthiomethyl)pyridine

2,6-Bis(2-pyridylthiomethyl)pyridine

C17H15N3S2 (325.0707)


   

4-Amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-on|4-amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-one

4-Amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-on|4-amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-one

C9H16N3O8P (325.0675)


   

midazolam

midazolam

C18H13ClFN3 (325.0782)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   

4-(3-Chloro-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-carboxylic acid

4-(3-Chloro-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-carboxylic acid

C19H16ClNO2 (325.087)


   

Diniconazole M

Diniconazole-M

C15H17Cl2N3O (325.0749)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Diniconazole (+)-form

Diniconazole (+)-form

C15H17Cl2N3O (325.0749)


   

N-BOC-BELTA-ALANINE-BELTA-2-CHLOROPHENYL-N-CARBOXYANHYDRIDE

N-BOC-BELTA-ALANINE-BELTA-2-CHLOROPHENYL-N-CARBOXYANHYDRIDE

C15H16ClNO5 (325.0717)


   

(S)-3-(Methylthio)pyrrolidine-3-carboxylic acid Methyl ester L-tartarate

(S)-3-(Methylthio)pyrrolidine-3-carboxylic acid Methyl ester L-tartarate

C11H19NO8S (325.0831)


   

2-(2-bromophenyl)-6-butyl-1,3,6,2-dioxazaborocane

2-(2-bromophenyl)-6-butyl-1,3,6,2-dioxazaborocane

C14H21BBrNO2 (325.0849)


   

6-Butyl-2-(3-bromophenyl)-1,3,6,2-dioxazaborocane

6-Butyl-2-(3-bromophenyl)-1,3,6,2-dioxazaborocane

C14H21BBrNO2 (325.0849)


   

6-Butyl-2-(4-bromophenyl)-1,3,6,2-dioxazaborocane

6-Butyl-2-(4-bromophenyl)-1,3,6,2-dioxazaborocane

C14H21BBrNO2 (325.0849)


   

Diphenyl anilinophosphonate

Diphenyl anilinophosphonate

C18H16NO3P (325.0868)


   

tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate

tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate

C15H20BrNO2 (325.0677)


   

5-[N-(3,5-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE

5-[N-(3,5-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE

C11H9F6N5 (325.0762)


   

2-amino-N-[2-[(4-methyl-2-oxochromen-7-yl)amino]-2-oxoethyl]acetamide,hydrochloride

2-amino-N-[2-[(4-methyl-2-oxochromen-7-yl)amino]-2-oxoethyl]acetamide,hydrochloride

C14H16ClN3O4 (325.0829)


   

4-bromo-N-cyclohexyl-2-ethoxybenzamide

4-bromo-N-cyclohexyl-2-ethoxybenzamide

C15H20BrNO2 (325.0677)


   

N-[(4-CHLORO-PHENYL)-(2-HYDROXY-NAPHTHALEN-1-YL)-METHYL]-ACETAMIDE

N-[(4-CHLORO-PHENYL)-(2-HYDROXY-NAPHTHALEN-1-YL)-METHYL]-ACETAMIDE

C19H16ClNO2 (325.087)


   

1-Pyrrolidinecarboxylic acid, 2-(4-bromophenyl)-, 1,1-dimethylethyl ester, (2R)-

1-Pyrrolidinecarboxylic acid, 2-(4-bromophenyl)-, 1,1-dimethylethyl ester, (2R)-

C15H20BrNO2 (325.0677)


   

Boronic acid, B-​[4-​[[[4-​(trifluoromethoxy)​phenyl]​amino]​carbonyl]​phenyl]​-

Boronic acid, B-​[4-​[[[4-​(trifluoromethoxy)​phenyl]​amino]​carbonyl]​phenyl]​-

C14H11BF3NO4 (325.0733)


   

3-Benzoyl-1-tosylpyrrole

3-Benzoyl-1-tosylpyrrole

C18H15NO3S (325.0773)


   

benzyl 4-(2-bromoethyl)piperidine-1-carboxylate

benzyl 4-(2-bromoethyl)piperidine-1-carboxylate

C15H20BrNO2 (325.0677)


   

tert-butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate

tert-butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate

C15H20BrNO2 (325.0677)


   

Methanone, [4-amino-2-(ethylthio)-5-pyrimidinyl](2,3-difluoro-6-Methoxyphenyl)-

Methanone, [4-amino-2-(ethylthio)-5-pyrimidinyl](2,3-difluoro-6-Methoxyphenyl)-

C14H13F2N3O2S (325.0697)


   

2-[(4-Chloroanilino)methylidene]-5-phenylcyclohexane-1,3-dione

2-[(4-Chloroanilino)methylidene]-5-phenylcyclohexane-1,3-dione

C19H16ClNO2 (325.087)


   

2-(Anilinomethylidene)-5-(3-chlorophenyl)cyclohexane-1,3-dione

2-(Anilinomethylidene)-5-(3-chlorophenyl)cyclohexane-1,3-dione

C19H16ClNO2 (325.087)


   

(R)-(+) 5(9BH)-Oxo-9B-phenyl-2,3-dihydrothiazolo[2,3-A]isoindol-3-carboxylic acid methyl ester

(R)-(+) 5(9BH)-Oxo-9B-phenyl-2,3-dihydrothiazolo[2,3-A]isoindol-3-carboxylic acid methyl ester

C18H15NO3S (325.0773)


   

Basimglurant

Basimglurant

C18H13ClFN3 (325.0782)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1]. Basimglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

3-amino-N-[3-(triluoromethyl)benzoyl]pyrazine-2-carbohydrazide

3-amino-N-[3-(triluoromethyl)benzoyl]pyrazine-2-carbohydrazide

C13H10F3N5O2 (325.0787)


   

beta-xylosyl-(1->3)-D-galacturonate

beta-xylosyl-(1->3)-D-galacturonate

C11H17O11- (325.0771)


   

2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylate

2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylate

C12H13N4O7- (325.0784)


   

2-(1,3-dioxo-2-isoindolyl)-N-(3-nitrophenyl)acetamide

2-(1,3-dioxo-2-isoindolyl)-N-(3-nitrophenyl)acetamide

C16H11N3O5 (325.0699)


   

3-(1,3-Benzothiazol-2-yl)propanoic acid phenacyl ester

3-(1,3-Benzothiazol-2-yl)propanoic acid phenacyl ester

C18H15NO3S (325.0773)


   
   
   
   

Dihyroxy-1H-indole glucuronide I

Dihyroxy-1H-indole glucuronide I

C14H15NO8 (325.0798)


   

4-hydroxy-8-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3-benzoxazin-2-one

4-hydroxy-8-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3-benzoxazin-2-one

C14H15NO8 (325.0798)


   

4-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboimidothioic acid

4-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboimidothioic acid

C12H15N5O4S (325.0845)


   

3-(4-hydroxy-3-nitrophenyl)-5-nitroso-4-phenyl-1h-pyrrol-2-ol

3-(4-hydroxy-3-nitrophenyl)-5-nitroso-4-phenyl-1h-pyrrol-2-ol

C16H11N3O5 (325.0699)


   

1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-1,2,3,4,6,7-hexol

1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-1,2,3,4,6,7-hexol

C14H15NO8 (325.0798)


   

4-hydroxy-8-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1,3-benzoxazin-2-one

4-hydroxy-8-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1,3-benzoxazin-2-one

C14H15NO8 (325.0798)


   

14-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaen-12-one

14-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaen-12-one

C20H11N3O2 (325.0851)


   

14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,11(15),13,16,19,21-decaen-12-one

14-hydroxy-3,13,18-triazahexacyclo[14.6.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁹,²³]tricosa-1(23),2(10),4,6,8,11(15),13,16,19,21-decaen-12-one

C20H11N3O2 (325.0851)


   

4-(4-hydroxy-3-nitrophenyl)-5-nitroso-3-phenyl-1h-pyrrol-2-ol

4-(4-hydroxy-3-nitrophenyl)-5-nitroso-3-phenyl-1h-pyrrol-2-ol

C16H11N3O5 (325.0699)